AAIC Investment has announced the successful second close of the Africa Innovation & Healthcare Fund (AHF) II, securing an additional $40 million in funding. This brings the total raised for AHF II to $87 million, a significant step towards their final goal of $150 million. The fund is dedicated to supporting innovative healthcare solutions across Africa.
Key Details:
- Investors and Supporters:
- AHF II received funding from notable entities including Asahi Intec, Eisai, Ohara Pharmaceutical Industry, Marubeni, Development Bank of Japan, and TOPPAN Holdings, among others.
- Marubeni, a returning investor, demonstrates continued support for AAIC Investment’s healthcare initiatives.
- AHF I Accomplishments:
- AHF I, launched in 2017, successfully invested in 30 companies, fulfilling its mission in the healthcare sector.
- AHF II Portfolio:
- AHF II has already invested in 15 companies, including Aumet (a pharmaceutical B2B marketplace in Jordan, Egypt, Turkey, and Saudi Arabia), The Baobab Network (a Nairobi-based startup accelerator), CredAble (a digital banking service for sub-Saharan Africa), and Yodawy (a pharmacy benefit management service in Egypt).
- AHF’s Impactful Mission:
- The Africa Innovation & Healthcare Fund focuses on supporting and nurturing innovative healthcare solutions across the African continent. This initiative addresses critical healthcare challenges and contributes to the advancement of the healthcare sector in the region.
Conclusion:
The successful second close of the Africa Innovation & Healthcare Fund II, with an additional $40 million in funding, highlights the strong support and interest in innovative healthcare solutions in Africa. With a total of $87 million raised, AAIC Investment is making significant strides towards their ultimate goal of $150 million. The fund’s investments in various healthcare startups demonstrate a commitment to driving positive change in the healthcare sector across the continent.